ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
포유류 세포은행 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 28억 2,000만 달러에서 2025년에는 31억 4,000만 달러에 달하고, CAGR 11.5%로 확대될 전망입니다. 이러한 성장은 단일클론항체에 대한 수요 증가, 바이오 의약품 연구개발 투자 증가, GMP 준수를 위한 규제 요건 확대, 포유류 발현 시스템의 이용 확대, 생물학적 제형 승인 증가 등과 관련이 있습니다.
포유류 세포은행 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.1%로 47억 9,000만 달러로 성장할 전망입니다. 예측 기간에 예상되는 성장은 세포 및 유전자 치료에 대한 수요 증가, 맞춤 의료의 보급, 바이오 제조 인프라에 대한 투자 증가, 바이오시밀러 및 바이오베터 개발의 확대, 팬데믹 대책과 백신 제조의 강화에 기인할 것으로 예상됩니다. 예측 기간 중 주요 동향으로는 자동화와 디지털 추적의 통합, 세포 배양 기술의 발전, 재생 의료의 진전, 무혈청 및 무단백 배지의 개발, 동결보존과 분석 기술의 개선 등이 있습니다.
세포 기반 치료에 대한 수요 증가는 포유류 세포은행 시장의 확대를 크게 촉진할 것으로 예측됩니다. 세포 기반 치료에는 살아있는 세포(주로 변형 또는 조작된 세포)를 사용하여 손상된 조직과 기관을 복구, 대체 및 재생하는 고급 치료가 포함되어 다양한 질병에 대한 표적 솔루션을 제공합니다. 만성 질환과 희귀질환이 확산됨에 따라 더욱 효과적이고 정밀한 치료에 대한 요구가 커지고 있습니다. 포유류 세포은행은 일관적이고 고품질의 세포 소스를 제공하고 재생 치료의 개발과 생산에서 안전성, 확장성 및 신뢰성을 보장함으로써 이러한 치료를 지원하는 데 중요한 역할을 수행합니다. 예를 들어, 미국 유전자세포치료학회(American Society of Gene and Cell Therapy)는 2024년 4월 임상 파이프라인에 있는 치료법의 수가 증가하였고, 1상 임상시험은 2022년 후반부터 11%라는 가장 높은 성장을 나타내고 있다고 보고했습니다. 이러한 세포 기반 치료에 대한 수요의 급증은 포유류 세포은행 시장의 성장을 뒷받침하고 있습니다.
만성 질환의 증가는 포유류 세포은행 시장의 성장을 가속하고 있습니다. 만성 질환은 치료가 아닌 지속적인 관리를 필요로 하는 장기적인 질환으로, 특히 세계 인구의 노화에 따라 유병률이 증가하고 있습니다. 노인은 지속적인 치료가 필요한 만성 질환에 걸리기 쉽습니다. 포유류 세포은행은 일관적이고 신뢰할 수 있는 세포 기반 치료법 및 생물학적 제제의 생성을 위해 고품질의 안정한 세포를 공급함으로써 이러한 질병의 치료를 지원합니다. 예를 들어 국제당뇨병연합은 2025년 4월, 2024년에는 20세에서 79세의 성인 약 5억 8,900만명이 당뇨병을 앓고 있었다고 보고하였고, 이 숫자는 2050년까지 8억 5,300만명으로 증가할 것으로 예측했습니다. 만성 질환의 이환율이 계속 증가함에 따라 포유류 세포은행 서비스에 대한 수요도 증가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 포유류 세포은행 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 포유류 세포은행 시장 : 성장률 분석
세계의 포유류 세포은행 시장 실적 : 규모와 성장(2019-2024년)
세계의 포유류 세포은행 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 포유류 세포은행 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 포유류 세포은행 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
마스터 세포은행
제조용 세포은행
세계의 포유류 세포은행 시장 : 세포 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
차이니즈 햄스터 난소 포유류 세포은행(CHO)
아기 햄스터 신장(BHK)
비분비성(NS0)
YB2/0과 P2/0
인간 배아 신장 293(HEK293)과 그 유도체
헨리에타 랙스(HELA)
세계의 포유류 세포은행 시장 : 보관 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
액체 질소
온도조절 냉동고
급속 동결
세계의 포유류 세포은행 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의약품 개발
백신 생산
유전자 치료
단일클론항체 생산
세계의 포유류 세포은행 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
학술기관 및 연구기관
바이오의약품기업
수탁연구기관(CRO)
세계의 포유류 세포은행 시장 세분화 : 마스터 세포은행: 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
재조합 세포 라인
하이브리도마 세포주
1차 세포 라인
유전자 변형 세포 라인
바이러스 벡터 생산 세포주
세계의 포유류 세포은행 시장 세분화 : 제조용 세포은행 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
현재의 적정 제조 기준(cGMP)에 준거한 세포은행
연구용 세포은행
임상시험용 세포은행
상업생산용 세포은행
세포은행의 안정성 시험
제7장 지역별/국가별 분석
세계의 포유류 세포은행 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 포유류 세포은행 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
포유류 세포은행 시장 : 경쟁 구도
포유류 세포은행 시장 : 기업 프로파일
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Eurofins Scientific SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Charles River Laboratories International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Catalent Inc.
Sartorius Stedim Biotech SA
Samsung Biologics Co. Ltd.
CMIC Holdings Co. Ltd.
WuXi Biologics Inc.
Fujifilm Diosynth Biotechnologies Inc.
Evotec SE
AGC Biologics Inc.
CordenPharma International GmbH
GenScript ProBio Co. Ltd.
Syngene International Limited
KBI Biopharma Inc.
Rentschler Biopharma SE
BioVectra Inc.
Polpharma Biologics SA
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
포유류 세포은행 시장(2029년) : 새로운 기회를 제공하는 국가
포유류 세포은행 시장(2029년) : 새로운 기회를 제공하는 부문
포유류 세포은행 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Mammalian cell banking is the organized procedure of producing, preserving, and storing well-characterized mammalian cell stocks under strict conditions, typically at very low temperatures, to ensure their long-term survival, genetic consistency, and functional performance. This method maintains the cells' uniformity, prevents contamination, and preserves their original traits over time, providing a reliable and standardized resource for future use.
The primary types of products in mammalian cell banking are master cell bank and working cell bank. A master cell bank (MCB) is a carefully prepared and extensively characterized collection of cells stored in multiple vials under controlled cryogenic conditions. It includes various cell types such as Chinese hamster ovary (CHO), baby hamster kidney (BHK), non-secreting 0 (NS0), YB2/0 and P2/0, human embryonic kidney 293 (HEK293) and derivatives, and HeLa cells. Storage methods include liquid nitrogen, controlled-rate freezing, and flash freezing. Master cell banks are used in drug development, vaccine production, gene therapy, and monoclonal antibody production, serving end users such as academic and research laboratories, biopharmaceutical companies, and contract research organizations (CROs).
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The mammalian cell banking market research report is one of a series of new reports from The Business Research Company that provides mammalian cell banking market statistics, including mammalian cell banking industry global market size, regional shares, competitors with a mammalian cell banking market share, detailed mammalian cell banking market segments, market trends and opportunities, and any further data you may need to thrive in the mammalian cell banking industry. This mammalian cell banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mammalian cell banking market size has grown rapidly in recent years. It will grow from $2.82 billion in 2024 to $3.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth observed during the historic period can be linked to increasing demand for monoclonal antibodies, higher investment in biopharmaceutical research and development, expansion of regulatory requirements for GMP compliance, greater use of mammalian expression systems, and a rise in approvals of biologic drugs.
The mammalian cell banking market size is expected to see rapid growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth projected for the forecast period can be attributed to increasing demand for cell and gene therapies, wider adoption of personalized medicine, rising investment in biomanufacturing infrastructure, expansion of biosimilar and biobetter development, and strengthened pandemic preparedness and vaccine production. Key trends during the forecast period include the integration of automation and digital tracking, advancements in cell culture technologies, progress in regenerative medicine, development of serum-free and protein-free media, and improvements in cryopreservation and analytical techniques.
The growing demand for cell-based therapies is expected to significantly drive the expansion of the mammalian cell banking market. Cell-based therapies involve advanced treatments using living, often modified or engineered, cells to repair, replace, or regenerate damaged tissues and organs, offering targeted solutions for various diseases. As chronic and rare diseases become more prevalent, there is an increasing need for more effective and precise treatments. Mammalian cell banking plays a key role in supporting these therapies by providing a consistent, high-quality cell source, ensuring safety, scalability, and reliability in the development and production of regenerative treatments. For example, the American Society of Gene and Cell Therapy reported in April 2024 that the number of therapies in clinical pipelines has grown, with Phase I trials showing the strongest growth of 11% since late 2022. This surge in demand for cell-based therapies is therefore fueling the growth of the mammalian cell banking market.
The rise in chronic diseases is driving the growth of the mammalian cell banking market. Chronic diseases are long-term conditions that require ongoing management instead of a cure, and their prevalence is increasing, particularly as the global population ages. Older individuals are more prone to developing chronic conditions that demand continuous care. Mammalian cell banking aids in treating these conditions by supplying high-quality, stable cells for the creation of consistent, reliable cell-based therapies and biologics. For instance, the International Diabetes Federation reported in April 2025 that around 589 million adults aged 20 to 79 were living with diabetes in 2024, and this figure is projected to rise to 853 million by 2050. As the incidence of chronic diseases continues to grow, the demand for mammalian cell banking services is also increasing.
Companies in the mammalian cell banking market are advancing the field by developing innovative stable cell line systems that improve cell line productivity, ensure long-term genetic stability, and streamline biopharmaceutical manufacturing. Stable cell line systems are engineered mammalian cells that can consistently produce specific proteins or therapeutic molecules across generations with high genetic stability. For example, WuXi Biologics, a biopharmaceutical company based in China, introduced the WuXia293 Stable platform in August 2024. This HEK293-based stable cell line system is designed for the development and production of challenging biologic molecules. By using proprietary cell line development technology, the platform ensures stable expression, consistent quality, and scalable production, overcoming challenges typically seen with traditional CHO cell systems, such as low yields and compromised quality. The WuXia293 Stable platform provides higher protein yields, better human-like glycosylation, and more efficient production for clinical and commercial use.
Major players in the mammalian cell banking market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, Eurofins Scientific SE, Charles River Laboratories International Inc., Catalent Inc., Sartorius Stedim Biotech S.A., Samsung Biologics Co. Ltd., CMIC Holdings Co. Ltd., WuXi Biologics Inc., Fujifilm Diosynth Biotechnologies Inc., Evotec SE, AGC Biologics Inc., CordenPharma International GmbH, GenScript ProBio Co. Ltd., Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, BioVectra Inc., Polpharma Biologics S.A., and Abzena plc.
North America was the largest region in the mammalian cell banking market in 2024. The regions covered in mammalian cell banking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the mammalian cell banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mammalian cell banking market consists of sales of cryopreservation media, cell culture reagents, storage vials, cryogenic storage equipment, and quality control kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mammalian Cell Banking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mammalian cell banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mammalian cell banking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell banking market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Master Cell Bank; Working Cell Bank
2) By Cell Type: Chinese Hamster Ovary Mammalian Cell Banking (CHO); Baby Hamster Kidney (BHK); Non-Secreting 0 (NS0); YB2/0 And P2/0; Human Embryonic Kidney 293 (HEK293) And Derivatives; Henrietta Lacks (HELA)
2) By Working Cell Bank: Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks; Research-Grade Cell Banks; Clinical Trial Cell Banks; Commercial Production Cell Banks; Stability Testing Cell Banks
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Mammalian Cell Banking Market Characteristics
3. Mammalian Cell Banking Market Trends And Strategies
4. Mammalian Cell Banking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Mammalian Cell Banking Growth Analysis And Strategic Analysis Framework
5.1. Global Mammalian Cell Banking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mammalian Cell Banking Market Growth Rate Analysis
5.4. Global Mammalian Cell Banking Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mammalian Cell Banking Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mammalian Cell Banking Total Addressable Market (TAM)
6. Mammalian Cell Banking Market Segmentation
6.1. Global Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Master Cell Bank
Working Cell Bank
6.2. Global Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chinese Hamster Ovary Mammalian Cell Banking (CHO)
Baby Hamster Kidney (BHK)
Non-Secreting (NS0)
YB2/0 And P2/0
Human Embryonic Kidney 293 (HEK293) And Derivatives
Henrietta Lacks (HELA)
6.3. Global Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liquid Nitrogen
Controlled Rate Freezer
Flash Freezing
6.4. Global Mammalian Cell Banking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Development
Vaccine Production
Gene Therapy
Monoclonal Antibody Production
6.5. Global Mammalian Cell Banking Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic And Research Laboratories
Biopharmaceutical Companies
Contract Research Organizations (CROs)
6.6. Global Mammalian Cell Banking Market, Sub-Segmentation Of Master Cell Bank, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Cell Lines
Hybridoma Cell Lines
Primary Cell Lines
Genetically Engineered Cell Lines
Viral Vector Producing Cell Lines
6.7. Global Mammalian Cell Banking Market, Sub-Segmentation Of Working Cell Bank, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Current Good Manufacturing Practice (cGMP)-Compliant Cell Banks
Research-Grade Cell Banks
Clinical Trial Cell Banks
Commercial Production Cell Banks
Stability Testing Cell Banks
7. Mammalian Cell Banking Market Regional And Country Analysis
7.1. Global Mammalian Cell Banking Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mammalian Cell Banking Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
